Search Login Register
tirofiban
(Aggrastat)
Summary
Description:
platelet glycoprotein-IIb/IIIa receptor antagonist; structure given in first source
Also Known As:
Aggrastat; Agrastat; Cahill May Roberts brand of tirofiban hydrochloride monohydrate; L 700462; L-700,462 Show All >>
Networked: 560
relevant articles (82 outcomes,
185 trials/studies)
for this Drug
Key Diseases for which tirofiban is
Relevant
-
Myocardial Infarction
:
27 outcomes 96 studies in 234 results
-
Acute Coronary Syndrome
:
20 outcomes 43 studies in 126 results
-
Hemorrhage
:
14 outcomes 18 studies in 111 results
-
Unstable Angina
:
11 outcomes 24 studies in 63 results
-
Thrombosis (Thrombus)
:
11 outcomes 12 studies in 96 results
Show All >>
Drugs Related to tirofiban
-
Heparin (Liquaemin)
-
Glycoproteins (Glycoprotein)
-
Aspirin (Acetylsalicylic Acid)
-
abciximab (ReoPro)
-
Enoxaparin (Lovenox)
-
eptifibatide (Integrilin)
-
tirofiban (Aggrastat)
-
omega-Chloroacetophenone (Mace)
-
Platelet Membrane Glycoprotein IIb
-
clopidogrel (Plavix)
Show All >>
Therapies Related to tirofiban
-
Angioplasty (Angioplasty, Transluminal)
-
Stents
-
Drug-Eluting Stents
-
Coronary Balloon Angioplasty (Percutaneous Transluminal Coronary Angioplasty)
-
Catheters
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.